Development of a Scalable Synthesis toward a KRAS G12C Inhibitor Building Block Bearing an All-Carbon Quaternary Stereocenter, Part 2: Asymmetric Synthesis via Shi Epoxidation

被引:4
|
作者
Tan, Zhulin [1 ]
Ju, Xuan [1 ]
Wu, Hao [1 ]
Dong, Weitong [1 ]
Leung, Joyce C. [1 ]
Hou, Xiaowen [1 ]
Lee, Heewon [1 ]
Granger, Alice [2 ]
Paolillo, Joshua M. [1 ]
Dimeo, Susan V. [1 ]
Chen, Chengsheng [1 ]
Wu, Linglin [1 ]
Lorenz, Jon C. [1 ]
Sarvestani, Max [1 ]
Buono, Frederic [1 ]
Frutos, Rogelio [1 ]
Tampone, Thomas G. [1 ]
Huang, Xiaojun [3 ]
Zhang, Gulin [3 ]
Wang, Yuwen [1 ]
Spinelli, Earl [1 ]
Lei, Zhen [1 ]
Song, Jinhua J. [1 ]
机构
[1] Boehringer Ingelheim Pharmaceut Inc, Dept Chem Dev, Ridgefield, CT 06877 USA
[2] Boehringer Ingelheim Pharmaceut Inc, Dept Mat & Analyt Sci, Ridgefield, CT 06877 USA
[3] Porton Pharma Solut Ltd, Shanghai Res & Dev Ctr, Shanghai 201100, Peoples R China
关键词
enyne; Shi epoxidation; LaCl3 center dot 2LiCl; epoxide opening; pre-IBS; organocatalyst; HYDROGEN-PEROXIDE; MESO-EPOXIDES; OXIDATION; CATALYSTS; ALCOHOLS; ALKYNES;
D O I
10.1021/acs.oprd.3c00363
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
The development of a scalable asymmetric synthesis of KRAS G12C inhibitor building block 1 is described. The all-carbon quaternary stereocenter was installed enantioselectively via Shi epoxidation, followed by a newly discovered regioselective LaCl3 center dot 2LiCl-catalyzed epoxide opening. Subsequent organocatalyzed oxidation provided the requisite ketone, which underwent the final assembly of the heterocyclic core, delivering 1 with high chemical and enantiomeric purities in 40% overall yield in only five steps, enabling robust and rapid manufacturing of over 300 kg of 1.
引用
收藏
页码:78 / 91
页数:14
相关论文
empty
未找到相关数据